Domain: Diagnosis/Neurogenetics
Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness
22 Nov. 2022
Speaker: Harro Seelaar & Dario Saracino
Erasmus University Medical Center, Rotterdam, Netherlands;
APHP – Pitié-Salpêtrière Hospital, Paris, France
When is it appropriate to suspect a metabolic disorder in a child with chorea?
VPS13A and XK bulk lipid transfer diseases (formerly the now obsolete Levine-Critchley syndrome)
DBS in Dystonia – Targets, programming and therapeutic challenges
Krabbe disease – natural history and treatment options
CACNA1A-related disorders: clinical presentation and therapeutic options
Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
27 Sep. 2022
Speaker: Daniel Weiß
Hertie Institute for Clinical Brain Research, University of Tübingen, Germany
Tau-targeting Therapies: Where are we heading to?
Vanishing white matter
13 Sep. 2022
Speaker: Marjo van der Knaap
VU University Medical Center Amsterdam, Netherlands
Young onset Parkinson’s disease – What is the difference?
Magnetic resonance imaging in the diagnostic assessment of cerebellar ataxias
28 Jun. 2022
Speaker: Jennifer Faber
German center for neurodegenerative disorders (DZNE), Bonn, Germany
Biofluid biomarkers in atypical parkinsonism
Basal ganglia diseases in childhood
The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’
5 Apr. 2022
Speaker: Robert Rusina & Zsolt Cséfalvay
Thomayer Hospital, Prague, Czech Republic; Comenius University in Bratislava, Slovakia
Measuring disease severity in chronic progressive myelopathy
Brain Development in Huntington’s Disease
New MDS criteria for clinical diagnosis of MSA
15 Feb. 2022
Speaker: Gregor Wenning & Iva Stankovic
Medical University Innsbruck, Austria; University of Belgrade, Serbia
The overlap between the spectrum of frontotemporal dementias and atypical Parkinsonism
Pure autonomic failure
Clinical outcome assessments in Ataxias
Pelizaeus-Merzbacher disease and related disorders (pediatric focus)
26 Oct. 2021
Speaker: Nicole Wolf
VU University Medical Center Amsterdam, Netherlands;
Emma Children’s Hospital, Amsterdam, Netherlands
Functional gait disorders: a sign-based approach
X-Linked leukodystrophies – Update
Adult leukodystrophies/early symptoms of late-onset Leukodystrophies
Treatable dystonia &dystonia in inborn errors of metabolism
Genetic forms of parkinson
Speech as a biomarker in ataxia: What can it tell us and how should we use it?
Metachromatic Leukodystrophy – update
15 Jun. 2021
Speaker: Samuel Gröschel & Ingeborg Krägeloh
University Hospital Tübingen, Germany
MRI pattern recognition in leukodystrophies
8 Jun. 2021
Speaker: Nicole Wolf
VU University Medical Center Amsterdam, Netherlands;
Emma Children’s Hospital, Amsterdam, Netherlands